Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rena M Conti

JAMA

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
JAMA|October 17, 2013
Drug discount program--replyRena M Conti
JAMA|April 24, 2013
Cost consequences of the 340B drug discount programRena M Conti, Peter B Bach
JAMA|April 26, 2025
Changes in Inhaled Steroid Dispensing to Children After Withdrawal of Brand-Name Fluticasone PropionateKao-Ping Chua, Anna Volerman, Rena M Conti
JAMA|June 21, 2019
Pharmacy Benefit Manager Reform: Lessons From OhioTrevor J Royce, Sheetal Kircher, Rena M Conti
JAMA|October 22, 2016
Pharmaceuticals and Public HealthRena M Conti, Rebekah E Gee, Joshua M Sharfstein
JAMA|February 27, 2018
Appropriately Framing Child Health Care Spending: A Prerequisite for Value ImprovementKao-Ping Chua, Rena M Conti, Gary L Freed
JAMA|January 13, 2022
US Insurer Spending on Ivermectin Prescriptions for COVID-19Kao-Ping Chua, Rena M Conti, Nora V Becker
JAMA|December 26, 2008
Use of prescription and over-the-counter medications and dietary supplements among older adults in the United StatesDima M Qato, G Caleb Alexander, Rena M Conti, et al.
JAMA|June 13, 2024
Association Between Cost Sharing and Naloxone Prescription DispensingKao-Ping Chua, Rena M Conti, Pooja Lagisetty, et al.
JAMA|April 25, 2023
Trends in Buprenorphine Initiation and Retention in the United States, 2016-2022Kao-Ping Chua, Thuy D Nguyen, Jason Zhang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
JAMA|October 17, 2013
Drug discount program--replyRena M Conti
JAMA|April 24, 2013
Cost consequences of the 340B drug discount programRena M Conti, Peter B Bach
JAMA|April 26, 2025
Changes in Inhaled Steroid Dispensing to Children After Withdrawal of Brand-Name Fluticasone PropionateKao-Ping Chua, Anna Volerman, Rena M Conti
JAMA|June 21, 2019
Pharmacy Benefit Manager Reform: Lessons From OhioTrevor J Royce, Sheetal Kircher, Rena M Conti
JAMA|October 22, 2016
Pharmaceuticals and Public HealthRena M Conti, Rebekah E Gee, Joshua M Sharfstein
JAMA|February 27, 2018
Appropriately Framing Child Health Care Spending: A Prerequisite for Value ImprovementKao-Ping Chua, Rena M Conti, Gary L Freed
JAMA|January 13, 2022
US Insurer Spending on Ivermectin Prescriptions for COVID-19Kao-Ping Chua, Rena M Conti, Nora V Becker
JAMA|December 26, 2008
Use of prescription and over-the-counter medications and dietary supplements among older adults in the United StatesDima M Qato, G Caleb Alexander, Rena M Conti, et al.
JAMA|June 13, 2024
Association Between Cost Sharing and Naloxone Prescription DispensingKao-Ping Chua, Rena M Conti, Pooja Lagisetty, et al.
JAMA|April 25, 2023
Trends in Buprenorphine Initiation and Retention in the United States, 2016-2022Kao-Ping Chua, Thuy D Nguyen, Jason Zhang, et al.
Pageof 1